January 2026
The global drug device combination products market size is projected to attain around USD 382.67 billion by 2035 from USD 165.26 billion in 2025 with a CAGR of 8.76%.
September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
September 2026
The global nasal mucosa drug supply device market size was evaluated at USD 10.03 billion in 2026 and is predicted to hit around USD 19.71 billion by 2035, growing at a CAGR of 7.80%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The implantable drug delivery devices market size is valued at USD 13.98 billion in 2026 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
September 2026
The global laparoscopy devices market size was valued at USD 9.94 billion in 2026 and is projected to surge around USD 19.00 billion by 2035 with a CAGR of 7.46%.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
September 2026
The global albinism drug market size was evaluated at USD 292.88 million in 2026 and is predicted to hit around USD 439.01 million by 2035, growing at a CAGR of 4.60%.
September 2026
The global herbal beauty products market size was valued at USD 101.95 billion in 2026 and is expected to hit around USD 158.12 billion by 2035, growing at a CAGR of 4.98%.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The dental 3D printing devices market size is calculated at USD 15.36 billion in 2026 and is projected to hit around USD 72.27 billion by 2035, with a solid CAGR of 18.92%.
September 2026
The global landscaping products market size reached USD 100.93 billion in 2026 and is projected to surpass around USD 170.46 billion by 2034, with a notable CAGR of 6.76%.
September 2026
The global digital patient monitoring devices market size is expected to hit around USD 144.16 billion by 2035 from USD 20.29 billion in 2026 with a CAGR of 24.43%.
September 2026
The global electrosurgical devices market size was valued at USD 7.40 billion in 2026 and is projected to hit around USD 10.03 billion by 2035 with a CAGR of 3.44%
September 2026
The global cardiovascular devices market size is expected to increase from USD 80.61 billion in 2026 to hit around USD 158.41 billion by 2035, with a CAGR of 7.81%.
September 2026
The global women’s health devices market size was valued at USD 42.57 billion in 2026 and is expected to reach over USD 82.03 billion by 2034 with a registered CAGR of 8.38% from 2025 to 2034.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The medical devices reimbursement market size reached USD 676.19 billion in 2026, with leading medical devices reimbursement market companies including UnitedHealth Group, Allianz, Nippon Life Insurance.
September 2026
The global drug discovery outsourcing market size was valued at USD 4.78 billion in 2026 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
September 2026
The global topical drug delivery market size was valued at USD 148.81 billion in 2026 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
September 2026
The elderly and disabled assistive devices market was valued at USD 33.26 billion in 2026, with leading companies including ai squared, drive medical, gn resound group, Invacare, Nordic capital
September 2026
The orthopedic regenerative surgical products market size is expected to hit around USD 8.17 billion by 2035 from USD 4.77 billion in 2026 with a CAGR of 6%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com